SC 13G: PRECISION BIOSCIENCES INC

AI Summary

SC 13G filing by PRECISION BIOSCIENCES INC.

Risk Assessment

Risk Level: low

FAQ

Filing Documents

• dtil_13gv3.htm (SC 13G) — 91KB
• 0001591986-24-000004.txt ( ) — 93KB

(a). Name of Issuer

Item 1(a). Name of Issuer: Precision Biosciences, Inc. (the “Issuer”)

(b). Address of Issuer’s Principal Executive Offices

Item 1(b). Address of Issuer’s Principal Executive Offices: 302 East Pettigrew Street, Suite A-100 Durham, NC, 27701

(a). Name of Persons Filing

Item 2(a). Name of Persons Filing: This with respect to the Common Stock (as defined in Item 2(d) below) of the Company: (i) Aquilo Capital, L.P. (ii) Aquilo Capital Management, LLC (iii) Marc Schneidman

(b). Address of Principal Business Office or, if none, Residence

Item 2(b). Address of Principal Business Office or, if none, Residence: (i) Aquilo Capital, L.P. One Letterman Drive, Suite D4900 Building D, The Presidio San Francisco, CA 94129 (ii) Aquilo Capital Management, LLC One Letterman Drive, Suite D4900 Building D, The Presidio San Francisco, CA 94129 (iii) Marc Schneidman c/o Aquilo Capital Management, LLC One Letterman Drive, Suite D4900 Building D, The Presidio San Francisco, CA 94129

(c). Citizenship

Item 2(c). Citizenship: (i) Aquilo Capital, L.P. – DE (ii) Aquilo Capital Management, LLC – CA (iii) Marc Schneidman – USA

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common Stock, par value 0.000005 per share (“Common Stock”)

(e). CUSIP Number

Item 2(e). CUSIP Number: 74019P108

If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: Not Applicable

Ownership

Item 4. Ownership (i) Aquilo Capital, L.P. (a) Amount beneficially owned: 466,767 (See Note 4) (b) Percent of class: 7.1% (See Note 5) (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 466,767 (See Note 4) (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 466,767 (See Note 4) (ii) Aquilo Capital Management, LLC (a) Amount beneficially owned: 662,659 (See Note 4) (b) Percent of class: 9.9% (See Note 6) (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 662,659 (See Note 4) (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 662,659 (See Note 4) (iii) Marc Schneidman (a) Amount beneficially owned: 662,659 (See Note 4) (b) Percent of class: 9.9% (See Note 6) (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 662,659 (See Note 4) (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 662,659 (See Note 4) CUSIP No. 74019P108 13G Page 5 of 7 Pages Note 4: Aquilo Capital Management, LLC is an investment adviser that is registered under the Investment Advisers Act of 1940. Aquilo Capital Management, LLC, which serves as the general partner and investment manager to investment funds, including but not limited to, Aquilo Capital, L.P., (collectively the "Funds"), may be deemed to be the beneficial owner of all shares of Common Stock held by the Funds. Mr. Schneidman, as Managing Member of Aquilo Capital Management, LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owner of all sh

Certifications

Item 10. Certifications: Each of the Reporting Persons makes the following certification: By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Date: March 18, 2024 AQUILO CAPITAL, L.P. By: Aquilo Capital Management, LLC, its General Partner By: /s/ Marc Schneidman Name: Marc Schneidman Title: Managing Member AQUILO CAPITAL MANAGEMENT, LLC By: /s/ Marc Schneidman Name: Marc Schneidman Title: Managing Member MARC SCHNEIDMAN By: /s/ Marc Schneidman CUSIP No. 74019P108 13G Page 6 of 7 Pages EXHIBIT A Joint Filing Agreement Pursuant to Rule 13d-1 This agreement is made pursuant to Rule 13d-l(k)(1) under the Securities Exchange Act of 1934, as amended (the "Act") by and among the parties listed below, each referenced to herein as a "Joint Filer". The Joint Filers agree that a statement of beneficial ownership as required by Sections 13(g) or 13(d) of the Act and the rules thereunder may be filed on each of his, her or its behalf on Schedule 13G or Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state that they each satisfy the requirements for making a joint filing under Rule 13d-1(k). Dated: March 18, 2024 AQUILO CAPITAL, L.P. By: Aquilo Capital Management, LLC, its General Partner By: /s/ Marc Schneidman Name: Marc Schneidman Title: Managing Member AQUILO CAPITAL MANAGEMENT, LLC By: /s/ Marc Schneidman Name: Marc Schneidma

View Full Filing

View this SC 13G filing on SEC EDGAR